Court upholds $142 million verdict against Pfizer over Neurontin

Administrator 0 Reuters Health
Print Email

(Reuters) - A federal appeals court said Pfizer Inc should pay about $142 million to cover costs for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a practice that has also earned it a hefty criminal fine.

Read Full Article


You can contact us at: